Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Annual Meeting

http://www.sec.gov/Archives/edgar/data/836564/000101968716005386/patriot_pre14a.htm

4. To approve an amendment to our certificate of incorporation, as amended, to effect a reverse stock split of shares of our issued and outstanding common stock, par value of $.00001 per share, at a ratio to be established by our board of directors in its discretion, of up to one for fifteen (but not less than one for five) (the “Reverse Stock Split”);
Share
New Message
Please login to post a reply